Lucidi Bruno (CIK 1829622) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-23). Recent activity: Buy AVIR (29,600 shares), Buy AVIR (29,600 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-23 | Atea Pharmaceuticals, Inc. (AVIR) | Director | Buy | 29,600 | $0 |
| 2025-06-24 | Atea Pharmaceuticals, Inc. (AVIR) | Director | Buy | 29,600 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-06-23